On or around 08/09/2017 (Other)
Filing Date: January 28, 2017
According to the Complaint, on January 8, 2017, the Company entered into an agreement and plan of merger (the “Merger Agreement”) with Takeda pursuant to which Takeda will acquire all outstanding shares of the Company with the Company stockholders receiving $24.00 per share in cash (the “Proposed Transaction”).
On January 19, 2017, defendants filed a Schedule 14D-9 (“Schedule”) with the United States Securities and Exchange Commission (“SEC”) in which the Company recommended stockholders tender their shares in favor of the Proposed Transaction. The Complaint alleges the Schedule failed to provide the Company’s stockholders with material information and/or provided them with materially misleading information thereby rendering the stockholders unable to make an informed decision as to how to tender their shares.
Company & Securities Information
Defendant: Ariad Pharmaceuticals, Inc.
Industry: Biotechnology & Drugs
Headquarters: United States
Ticker Symbol: ARIA
Company Market: NASDAQ
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Stephanie Baumann, et al. v. Ariad Pharmaceuticals, Inc., et al.
COURT: D. Massachusetts
DOCKET #: 17-CV-10153
JUDGE: Hon. Denise J. Casper
DATE FILED: 01/28/2017
CLASS PERIOD START: 01/08/2017
CLASS PERIOD END: 01/28/2017
PLAINTIFF FIRMS NAMED IN COMPLAINT:
Levi & Korsinsky (Stamford) 733 Summer Street, Suite 304, Levi & Korsinsky (Stamford), CT 06901 203-992-4523 ·
First Identified Complaint (FIC) Filings:
Class Action Complaint
Stipulation of Dismissal and [Proposed] Order
Stipulation of Dismissal and Order
U.S. District Court Civil Docket
—Reference Complaint Complaint Related Data is not available
Related District Court Filings
—Related District Court Filings Data is not available